SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,895.74 315.20
( 0.43%)

Global Indices

Nasdaq

51,370.81 -161.78
(-0.31%)

Dow Jones

7,725.73 -1.30
(-0.02%)

Hang Seng

66,308.10 794.11
(1.21%)

Nikkei 225

10,680.49 -24.77
(-0.23%)

Forex

USD-INR

95.73 0.08
(0.09%)

EUR-INR

109.20 -0.36
(-0.33%)

GBP-INR

127.12 -0.62
(-0.48%)

JPY-INR

0.61 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Aarti Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524348

INE767A01016

153.9159417

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AARTIDRUGS

23.09

3993.52

EPS(TTM)

Face Value()

Div & Yield %

18.95

0.46

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	2260.39	2173.65	2266.91	2497.97	2251.17	1914.89
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2260.39	2173.65	2266.91	2497.97	2251.17	1914.89
Other Income	2.59	13.57	4.18	2.23	4.77	9.69
Stock Adjustments	-6.62	-22.00	-26.77	6.72	77.94	9.08
Total Income	2256.36	2165.22	2244.32	2506.92	2333.88	1933.66
EXPENDITURE :
Raw Materials	1424.24	1376.63	1476.42	1723.25	1558.47	1148.99
Power & Fuel Cost	170.78	153.51	151.64	153.45	126.05	95.64
Employee Cost	85.03	73.88	70.20	64.30	57.17	55.60
Other Manufacturing Expenses	222.61	199.25	201.92	182.71	171.26	138.99
Selling & Administrative Expenses	80.32	74.83	63.27	89.25	89.75	76.70
Miscellaneous Expenses	8.29	8.37	7.52	5.68	5.24	6.72
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1991.28	1886.48	1970.96	2218.64	2007.95	1522.64
Operating Profit	265.09	278.74	273.36	288.28	325.94	411.02
Interest	28.14	32.20	33.21	36.18	23.05	25.71
Gross Profit	236.95	246.54	240.15	252.10	302.89	385.31
Depreciation	55.64	47.79	47.67	47.29	47.39	47.60
Profit Before Tax	181.31	198.75	192.48	204.81	255.50	337.71
Tax	7.23	37.94	49.60	53.25	65.50	84.50
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	4.85	3.50	1.00	-1.25	-5.00	-4.50
Reported Net Profit	169.22	157.31	141.88	152.81	195.00	257.71
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.17
Adjusted Net Profit	169.22	157.31	141.88	152.81	195.00	257.54
Adjustment below Net Profit	-16.92	-15.73	-13.32	0.00	-51.64	-69.90
P & L Balance brought forward	1126.48	1052.31	947.13	818.86	704.26	565.52
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	18.25	67.41	23.38	24.54	28.76	49.07
P & L Balance carried down	1260.53	1126.48	1052.31	947.13	818.86	704.26
Dividend	0.00	0.00	9.19	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	20.00	10.00	10.00	10.00	10.00	25.00
Dividend Per Share(Rs)	2.00	1.00	1.00	1.00	1.00	2.50
Earnings Per Share-Unit Curr	18.54	17.24	15.43	16.50	21.06	27.65
Earnings Per Share(Adj)-Unit Curr	18.54	17.24	15.43	16.50	21.06	27.65
Book Value-Unit Curr	153.92	137.10	127.83	120.34	104.99	92.23
Book Value(Adj)-Unit Curr	153.92	137.10	127.83	120.34	104.99	92.23

73,895.74 315.20 ( 0.43%)

51,370.81 -161.78 (-0.31%)

7,725.73 -1.30 (-0.02%)

66,308.10 794.11 (1.21%)

10,680.49 -24.77 (-0.23%)

95.73 0.08 (0.09%)

109.20 -0.36 (-0.33%)

127.12 -0.62 (-0.48%)

0.61 0.00 (-0.28%)